Mechanisms and future directions for angiogenesis-based cancer therapiesSCAPPATICCI, Frank A.Journal of clinical oncology. 2002, Vol 20, Num 18, pp 3906-3927, issn 0732-183X, SUPArticle

Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE TrialSPIGEL, David R; TOWNLEY, Peter M; WATERHOUSE, David M et al.Journal of clinical oncology. 2011, Vol 29, Num 16, pp 2215-2222, issn 0732-183X, 8 p.Article

Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancerBUKOWSKI, Ronald M; KABBINAVAR, Fairooz F; SCAPPATICCI, Frank A et al.Journal of clinical oncology. 2007, Vol 25, Num 29, pp 4536-4541, issn 0732-183X, 6 p.Article

Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failureTANNIR, Nizar M; WONG, Yu-Ning; GUPTA, Neeraj et al.European journal of cancer (1990). 2011, Vol 47, Num 18, pp 2706-2714, issn 0959-8049, 9 p.Article

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumabSCAPPATICCI, Frank A; SKILLINGS, Jamey R; HURWITZ, Herbert et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 16, pp 1232-1239, issn 0027-8874, 8 p.Article

Phase 2 Trial of Linifanib (ABT-869) in Patients With Unresectable or Metastatic Hepatocellular CarcinomaHANCHONGTOH; CHEN, Pei-Jer; JIANG QIAN et al.Cancer. 2013, Vol 119, Num 2, pp 380-387, issn 0008-543X, 8 p.Article

Statin-AE: A novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activitySCAPPATICCI, Frank A; CONTRERAS, Anthony; SMITH, Richard et al.Angiogenesis (London). 2001, Vol 4, Num 4, pp 263-268, issn 0969-6970Article